The complex interplay between metabolic health and liver function is a subject of intense scientific scrutiny. Central to this understanding is the Farnesoid X Receptor (FXR), a nuclear receptor that governs a range of physiological processes, including bile acid metabolism, glucose and lipid homeostasis, and inflammation. Obeticholic Acid (CAS 459789-99-2), a semi-synthetic bile acid analogue, has gained prominence as a potent and selective FXR agonist, offering significant promise in addressing various metabolic disorders and liver diseases.

As a powerful FXR agonist, Obeticholic Acid activates this receptor, thereby influencing the expression of numerous target genes. This activation is critical for modulating bile acid synthesis and transport, helping to prevent the pathological accumulation of bile acids in the liver. This characteristic is particularly relevant for conditions like cholestasis, where impaired bile flow can lead to liver damage. For researchers investigating these pathways, the opportunity to buy Obeticholic Acid is invaluable for their studies.

The therapeutic potential of Obeticholic Acid is being actively explored in the context of nonalcoholic steatohepatitis (NASH), a growing public health concern characterized by liver inflammation and fibrosis, often associated with metabolic syndrome. By targeting FXR, Obeticholic Acid has shown efficacy in preclinical models by reducing liver fat, inflammation, and fibrosis, making it a key focus in the search for effective NASH treatments. The role of Obeticholic Acid as an obeticholic acid research chemical is indispensable for preclinical and clinical investigations into these complex conditions.

Beyond NASH, Obeticholic Acid is also being studied for its effects on other metabolic dysfunctions, including improving insulin sensitivity and ameliorating symptoms of portal hypertension. These diverse applications highlight its broad impact on metabolic and liver health. The consistent demand for a high-quality obeticholic acid pharmaceutical chemical signifies its importance in the ongoing pharmaceutical research and development efforts.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting scientific research by providing Obeticholic Acid, a crucial tool for unraveling the complexities of metabolic disorders and liver diseases. Our high-purity compound enables researchers to conduct precise experiments, contributing to the development of novel therapies that can significantly improve patient outcomes and public health. By facilitating access to essential research chemicals like Obeticholic Acid, we aim to be a partner in scientific progress.